Targeting FMO3 suppresses the malignant phenotype of colorectal cancer: evidence from bioinformatics to functional experiments
FMO3 promotes malignant progression of colorectal cancer and may serve as a potential biomarker and therapeutic target. Further in vivo and mechanistic studies are warranted to validate these findings.
Authors
- Shuping Qiu
- Rong Su (ORCID: https://orcid.org/0009-0003-4765-6859)
- Hailong Li
- Hongwei Wang
- Cuncun Huang
- Lihua Shao
- Tinghong Jiao
- Zhe Jing
Institutions
- Gansu University of Traditional Chinese Medicine (CN)
- Integrated Chinese Medicine (China) (HK)
- Jingning County People's Hospital (CN)
Publication Details
- Journal
- Future Science OA
- Published
- 2026-02-21
- DOI
- https://doi.org/10.1080/20565623.2026.2629346
- Primary Topic
- FOXO transcription factor regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00